Cargando…
Publisher Correction: Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
Autores principales: | Ulz, Peter, Perakis, Samantha, Zhou, Qing, Moser, Tina, Belic, Jelena, Lazzeri, Isaac, Wölfler, Albert, Zebisch, Armin, Gerger, Armin, Pristauz, Gunda, Petru, Edgar, White, Brandon, Roberts, Charles E. S., John, John St., Schimek, Michael G., Geigl, Jochen B., Bauernhofer, Thomas, Sill, Heinz, Bock, Christoph, Heitzer, Ellen, Speicher, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7170910/ https://www.ncbi.nlm.nih.gov/pubmed/32313081 http://dx.doi.org/10.1038/s41467-020-15799-4 |
Ejemplares similares
-
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection
por: Ulz, Peter, et al.
Publicado: (2019) -
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
por: Belic, Jelena, et al.
Publicado: (2018) -
Multiplex genetic cancer testing identifies pathogenic mutations in TP53 and CDH1 in a patient with bilateral breast and endometrial adenocarcinoma
por: Heitzer, Ellen, et al.
Publicado: (2013) -
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
por: Zhou, Qing, et al.
Publicado: (2020) -
Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
por: Mohan, Sumitra, et al.
Publicado: (2014)